High Tech Pharm Co., Ltd. (KOSDAQ:106190)

High Tech Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	207,028	127,811	148,864	99,208	77,268	97,116
Market Cap Growth	23.78%	-14.14%	50.05%	28.39%	-20.44%	-25.75%
Enterprise Value	192,632	114,996	153,628	111,271	89,346	110,402
Last Close Price	19470.00	12020.00	13825.00	9147.57	7075.37	8836.82
PE Ratio	18.04	11.14	10.86	12.28	13.16	-
PS Ratio	2.95	1.82	1.92	1.29	0.75	1.33
PB Ratio	1.58	0.98	1.24	0.93	0.77	1.03
P/TBV Ratio	1.58	0.98	1.24	0.93	0.77	1.03
P/FCF Ratio	13.71	8.46	11.85	-	-	16.00
P/OCF Ratio	12.16	7.51	10.13	34.11	-	14.02
EV/Sales Ratio	2.74	1.64	1.98	1.45	0.87	1.51
EV/EBITDA Ratio	10.54	6.29	7.41	7.38	8.53	21.49
EV/EBIT Ratio	14.98	8.95	9.88	11.03	18.13	-
EV/FCF Ratio	12.76	7.62	12.23	-	-	18.19
Debt / Equity Ratio	0	0	0.07	0.15	0.16	0.17
Debt / EBITDA Ratio	0.00	0.00	0.39	1.09	1.57	3.11
Debt / FCF Ratio	0.00	0.00	0.64	-	-	2.63
Net Debt / Equity Ratio	-0.11	-0.11	0.00	0.10	0.09	0.04
Net Debt / EBITDA Ratio	-0.79	-0.79	0.01	0.74	0.82	0.65
Net Debt / FCF Ratio	-0.95	-0.95	0.02	-5.10	-1.96	0.55
Asset Turnover	0.50	0.50	0.56	0.57	0.81	0.58
Inventory Turnover	1.36	1.36	1.92	3.18	5.88	3.86
Quick Ratio	2.06	2.06	1.48	1.31	1.15	0.97
Current Ratio	5.67	5.67	3.39	2.48	1.64	1.78
Return on Equity (ROE)	9.16%	9.16%	12.09%	7.81%	6.06%	-1.30%
Return on Assets (ROA)	5.66%	5.66%	7.07%	4.72%	2.41%	-0.21%
Return on Invested Capital (ROIC)	9.26%	9.03%	10.48%	7.29%	4.79%	-0.41%
Return on Capital Employed (ROCE)	9.80%	9.80%	12.80%	9.00%	4.90%	-0.40%
Earnings Yield	5.54%	8.98%	9.21%	8.14%	7.60%	-1.26%
FCF Yield	7.29%	11.82%	8.44%	-2.20%	-5.64%	6.25%
Payout Ratio	9.27%	9.27%	5.17%	6.14%	6.04%	-
Buyback Yield / Dilution	-	-	-49.99%	33.33%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.